Scholtz & Company’s Johnson & Johnson JNJ Stock Holding History

Scholtz & Company’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,100	Closed	-$306K	–	66
2019 Q4	$306K	Buy	2,100 +475	+29%	+$64.4K	0.18%	53
2019 Q3	$210K	Sell	1,625 -25	-2%	-$3.29K	0.14%	53
2019 Q2	$230K	Sell	1,650 -20	-1%	-$2.77K	0.15%	56
2019 Q1	$233K	Sell	1,670 -5,831	-78%	-$781K	0.16%	49
2018 Q4	$968K	Buy	7,501 +4,501	+150%	+$628K	0.84%	28
2018 Q3	$415K	Hold	3,000	–	–	0.26%	46
2018 Q2	$364K	Sell	3,000 -1,400	-32%	-$175K	0.25%	46
2018 Q1	$564K	Sell	4,400 -1,085	-20%	-$147K	0.42%	41
2017 Q4	$766K	Buy	5,485 +1,085	+25%	+$151K	0.56%	41
2017 Q3	$572K	Buy	+4,400	New	+$583K	0.45%	45

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Scholtz & Company's JNJ Position: Q1 2020 in Review

Scholtz & Company sold out of Johnson & Johnson (JNJ) in Q1 2020, closing a stake of 2,100 shares — an estimated $306K sold.

Scholtz & Company first reported a position in JNJ in Q3 2017 and held it in 10 quarters. The position peaked at $968K in Q4 2018. 2,932 funds tracked by Wall St. Rank hold JNJ as of Q1 2020.

Scholtz & Company reported no remaining Johnson & Johnson position as of Q1 2020 after selling out during the quarter.
Scholtz & Company sold 2,100 Johnson & Johnson shares in Q1 2020, an estimated $306K.
Scholtz & Company first reported a position in Johnson & Johnson in Q3 2017 and held it in 10 quarters.
Scholtz & Company's Johnson & Johnson position peaked at $968K in Q4 2018.
2,932 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2020.

Based on Scholtz & Company's 13F filing for Q1 2020, filed 14 May 2020.